SCHEMBL15033477

SCHEMBL15033477

CCCOc1ccc(N2C(=O)C=CC2=O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 9/20 0.59
CACNA1B Q00975 2/20 0.56
APBA1 Q02410 2/20 0.56
FAAH O00519 3/20 0.54
ALDH1A1 P00352 5/20 0.50
HSP90AA1 P07900 2/20 0.50
HPGD P15428 2/20 0.50
HTT P42858 2/20 0.50
LMNA P02545 2/20 0.50
MEN1 O00255 1/20 0.50
PKM P14618 1/20 0.50
CCR6 P51684 1/20 0.50
KMT2A Q03164 1/20 0.50
ATM Q13315 1/20 0.50
MAPT P10636 2/20 0.49
KDM4E B2RXH2 1/20 0.49
POLB P06746 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
TDP1 Q9NUW8 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8542401 0.89 MGLL (0.62) MGLLCACNA1BAPBA1FAAHALDH1A1
SCHEMBL8526538 0.89 MGLL (0.62) MGLLCACNA1BAPBA1FAAHALDH1A1
SCHEMBL3003422 0.88 MGLL (0.62) MGLLFAAHHTTLMNATP53
SCHEMBL2997957 0.88 MGLL (0.62) MGLLFAAHHTTLMNATP53
SCHEMBL3668333 0.87 MGLL (0.60) MGLLCACNA1BAPBA1FAAHALDH1A1
SCHEMBL3676454 0.85 LMNA (0.66) MGLLCACNA1BAPBA1FAAHALDH1A1
SCHEMBL10297378 0.84 MGLL (0.62) MGLLCACNA1BAPBA1FAAHALDH1A1
SCHEMBL18840331 0.84 MGLL (0.56) MGLLCACNA1BAPBA1FAAHALDH1A1
SCHEMBL8528761 0.84 MGLL (0.56) MGLLCACNA1BAPBA1FAAHALDH1A1
SCHEMBL28773523 0.82 MGLL (0.55) MGLLCACNA1BAPBA1FAAHALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109593154-B Selenium-containing maleimide polymer and preparation method and application thereof 苏州大学 2021-03-12 CN claimed
CN-109593154-B Selenium-containing maleimide polymer and preparation method and application thereof 苏州大学 2021-03-12 CN disclosed
US-20130156795-A1 METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2013-06-20 US disclosed
US-20130156795-A1 METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2013-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130156795-A1 METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF MKI67, DCX, CTCF MGLL 4517/4885CACNA1B 4128/4885APBA1 2216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.